#Research « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘#Research’

CLIENT FEATURE: Red Light Holland $TRIP.ca iMicrodose Magic Truffle Distribution Agreement Catalyst for Growth $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM at 12:16 PM on Thursday, October 15th, 2020

(CSE: TRIP)

Red Light Holland’s iMicrodose packs are Available on Shelves in the Netherlands (18+) and online plus their Science and Innovation Division, Scarlette Lillie, is taking notice in the Longevity field, via their Jinfiniti arrangement.

It appears as if, Scarlette Lillie Science and Innovation’s goal is to support science and medical research without needing to raise 100’s millions of dollars while focusing on the digital experience and potential opt-in user data collection.

Red Light Holland and Scarlette Lillie is focused on education and information plus adult-responsible use of their iMicrodose packs.
Joined the Medical Psychedelics Working Group
- a consortium of drug science experts, leading academics and researchers, policy specialists and industry partners

Scarlette Lillie and Jinfiniti Precision Medicine

This relationship with Jinfiniti may allow Scarlette Lillie to add a novel component to expected clinical studies for psilocybin and truffles.
The knowledge that comes from this has the potential to not only influence the outcome of clinical studies but can also potentially lead to novel treatments for several disorders.

Virtual Reality Shopping Experience

Red Light Holland is creating a virtual reality shopping experience module, intended to explain the effects of microdosing of magic truffles on the human brain, as well as a virtual reality avatar that is centered around Red Light Holland’s brand.

The VR Module is expected to be completed in Q4 2020,
Educating and enabling individuals to make reasoned, informed decisions with respect to magic truffles and other psychedelic substances,
Enabling Red Light Holland to gather valuable data on user experience of synesthesia, loss of autonomy and suggestibility to inform further study and research in the psychedelic space.

The VR Avatar, which is expected to be completed in Q3 2020, is expected to assist Red Light Holland’s larger efforts towards reducing the stigma associated with, among other things, magic truffles and other psychedelic substances.

Red Light Holland’s Growth Potential

TRIP is established to grow, distribute and market a magic truffles to the legal, recreational market within the Netherlands

Red Light Holland has reached a Distribution Arrangement for iMicrodose Packs with a total of 8 Smart Shops Netherlands and expects that number to grow rapidly.
Red Light Holland iMicrodose Packs are currently available in 3 Smartshops and the rest are expected to be in Smartshops by the end of October, 2020
Red Light Holland iMicrodose Packs are available to the Netherlands, Adult market online at www.iMicrodose.nl and are offering a unique subscription model.
The sales and growth evolution of Red Light is just beginning

Red Light (to the best of our research) is the first public company selling psychedelic products on the market

Responsibility Toward Consumption

Responsible use requires users who are at a minimum 18 years old.
Red light is a self-regulated company and in accordance with the highest standards and compliance with all applicable laws.
Red Light Holland’s team includes Bruce Linton as their Chair of the Advisory Board, Tony Clement (former Canadian Health Minister) and World Famous Entertainer Russell Peters.
Red Light Holland has been featured in vice.com – www.Hightimes.com – the New York Observer – and mentioned on The Joe Rogan Experience.
Former Top Rated Host, CEO Todd Shapiro is clearly using his deep rooted celebrity connections to get incredible exposure on the Company.
This earned media to such a large audience is impressive for any small cap Company

Red Light Holland’s current market cap is approximately 20 million and appears to be low when comparing them to their peers, considering they currently have a product on shelves, while supporting science and innovation intelligently.

Peer Market cap Comparisons:

1. NUMI NUMINUS WELLNESS INC: $37,703,000

2. MYCO Mydecine Innovations Group Inc.: $48,829,000

3. MMED MIND MEDICINE (MINDMED) INC.: $391,733,000

FULL DISCLOSURE: Red Light Holland is an advertising client of AGORA Internet Relations Corp.

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles
Posted in AGORACOM Client Feature, All Recent Posts, Red Light Holland | Comments Off on CLIENT FEATURE: Red Light Holland $TRIP.ca iMicrodose Magic Truffle Distribution Agreement Catalyst for Growth $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Red Light Holland $TRIP.ca Reaches Distribution Arrangement for iMicrodose Packs with Smartshop Oss, in Oss, Netherlands $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM at 9:04 AM on Monday, October 5th, 2020

Toronto, Ontario–(Newsfile Corp. – October 5, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce their iMicrodose Packs (“iMicrodose Packs“) powered by Red Light Holland are expected to be available on by the end of October, 2020 in Smartshop Oss located at Walstraat 29, 5341 CJ Oss, Netherlands as Red Light Holland has reached a distribution agreement with Smartshop Oss.

Red Light Holland has also reached an agreement with Smartshop Oss to build and set up an iMicrodose Media Information Centre (“iMIC“) in Smartshop Oss, expected to be ready before the end of 2020.

“This is just another example on how aggressive we are by immediately increasing the ability for consumers, all over the Netherlands, to purchase our iMicrodose packs powered by Red Light Holland. It also instantly increases our brand’s visibility,” said Todd Shapiro, CEO and Director of Red Light Holland. “Equally as important, we are very excited to work with Shai Ramsahai and his team, as they are very familiar with the Truffles’ industry in the Netherlands. This once again proves how open and accepting the pioneers of the industry are, as they continue to welcome us with open arms, as together we plan on growing the market synergistically.”

“We are really happy to work with Red Light Holland. Todd and Hans Derix (President of Red Light Holland) have really impressed me with their early knowledge of the industry and their ability to instantly think of creative ideas to help capture a new customer base including their clever iMicrodose Media Information Centre (iMIC) to help educate consumers, which we are pleased to eventually have in Smartshop Oss. Their iMicrodose fridges are pretty cool too!” added Shai Ramsahai, CEO of Smartshop Oss.

Smartshop Oss is located at Walstraat 29, 5341 CJ Oss, on one of the main shopping streets in the city centre of Oss. Oss is a municipality and a city in the southern Netherlands, in the province of North Brabant.

Pictured: Smartshop Oss in Oss, Netherlands

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/65204_7ad16a927418686d_001full.jpg

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland $TRIP.ca Reaches Distribution Arrangement for iMicrodose Packs with Smartshop Oss, in Oss, Netherlands $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie, Announces Collaboration with Jinfiniti Precision Medicine to Pursue Clinical Study Insights $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM at 8:47 AM on Wednesday, September 30th, 2020

Scarlette Lillie Science and Innovation has secured a relationship with Jinfiniti Precision Medicine
Exploring the potential roles that psilocybin and truffles can play for age-related and psychiatric disorders

Toronto, Ontario–(Newsfile Corp. – September 30, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that its science division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has secured a relationship with Jinfiniti Precision Medicine (“Jinfiniti“) in order to explore the potential roles that psilocybin and truffles can play for age-related and psychiatric disorders. Jinfiniti has created a world class “AgingSOS” test panel that can detect key factors from blood that drive aging and other genetic instabilities. The speed and affordability of this test can allow for both company’s Scientists to clearly evaluate the potential for psilocybin treatments that go beyond what is currently being explored. The CEO of Jinfiniti is Dr. Jin-Xiong She, a professor at Augusta University in Georgia, USA, whose expertise is in the creation of biomarker panels. Jinfiniti’s state of the art panel is making it possible to extend the applicability of psilocybin.

“We are pleased to work with Scarlette Lillie, and we are excited to add this special dimension to their clinical study explorations as they emerge,” says Dr. She, CEO of Jinfiniti.

“The idea that psilocybin and truffles have deep physiological and medicinal effects that go beyond psychiatric applications is not new, but as a scientist, Scarlette Lillie is allowing me to truly explore whole new markets, with a rigorous biomarker panel. Additionally, this work has the potential to help us understand if there are unknown mechanisms at play for neurological and psychiatric disorders,” says Dr. Joseph Geraci, CEO of NetraMark Corp. and a scientific advisor to Red Light Holland. Dr. Geraci is helping to establish several clinical programs. He brings a deep knowledge of systems biology, medical science, and artificial intelligence to the team.

This relationship with Jinfiniti will allow Scarlette Lillie to add a novel component to expected clinical studies for psilocybin and truffles. The knowledge that comes from this has the potential to not only influence the outcome of clinical studies but can also potentially lead to novel treatments for several disorders.

“When you see brilliant Scientists like Dr. Joseph Geraci and Dr. Jin-Xiong She, a professor at Augusta University, show this much excitement, it gets me really excited!” Added Todd Shapiro, CEO and Director of Red Light Holland. “I’ve always made it very clear that as a company we take Science and Innovation very seriously. This is just another example of Scarlette Lillie moving forward intelligently with world class experts to hopefully help be a part of positive change.”

About Jinfiniti Precision Medicine

Jinfiniti is a precision medicine company that aims to increase the human healthspan. Using measures of key blood biomarkers, Jinfiniti is able to provide a detailed overview of individual aging health. Composed of researchers who met at the Medical College of Georgia, the Jinfiniti team is dedicated to the prevention of chronic disease and the promotion of longevity. Their novel approach to anti-aging practices involves conducting lab tests to measure aging biomarkers within the blood. This information then helps to guide individual lifestyle adjustments, leading to improved health and quality of life.

Jin-Xiong She, Ph.D., Professor at Augusta University
Founder & CEO
Jinfiniti Precision Medicine, Inc.
1120 15th Street, Augusta, GA 30912

About Red Light Holland Corp.

RLH is an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws. The Company’s brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops as well as its e-commerce platform, and are expected to be initially made available in the form of its previously announced Microdosing Packs.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer and Director
Tel: 647-204-7129

Email: [email protected]
Website: https://redlighttruffles.com

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie, Announces Collaboration with Jinfiniti Precision Medicine to Pursue Clinical Study Insights $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Red Light Holland $TRIP.ca iMicrodose Video with Todd Shapiro $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM at 11:15 AM on Monday, September 28th, 2020

Watch this til the end!

Some are talkers. Others are doers. We @redlightholland have delivered on our first promise. We have a long way to go but we are proud & truly believe this is a great start. Thanks for the support. 🙏

https://t.co/18T2PTmbTn $TRIP #MondayMotivation pic.twitter.com/YlneNNabku
— Todd Shapiro (@iamToddyTickles) September 28, 2020

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland $TRIP.ca iMicrodose Video with Todd Shapiro $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Red Light Holland $TRIP.ca Reaches Distribution Agreement for iMicrodose Packs $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM at 8:47 AM on Monday, September 28th, 2020

iMicrodose Packs powered by Red Light Holland are expected to be available early October 2020
Creating a iMicrodose Media Information Centre (“iMIC“) in Super Smart’s Tiel location, expected to be ready before the end of 2020

Toronto, Ontario–(Newsfile Corp. – September 28, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce their iMicrodose Packs (“iMicrodose Packs“) powered by Red Light Holland are expected to be available early October 2020 in PharmaDrug Inc.’s (“PharmaDrug”) wholly-owned subsidiary Interrobang Ltd.’s (doing business as Super Smart) (“Super Smart“) store in Tiel, The Netherlands, as Red Light Holland has reached a distribution agreement with Super Smart.

Red Light Holland has also reached an agreement with Super Smart to build and set up an iMicrodose Media Information Centre (“iMIC“) in Super Smart’s Tiel location, expected to be ready before the end of 2020.

“Super Smart’s vision and iMicrodose’s vision truly align,” said Todd Shapiro, CEO and Director of Red Light Holland. “Both companies are focused on educating, informing and modernizing the psychedelic industry within the Netherlands. We are very excited to soon have another store where our product is sold to expand our exposure and marketplace. Equally as important, we are proud to set up our first iMicrodose Media Information Centre – iMIC – where we plan on eventually providing Super Smart with our Virtual Reality Headset where consumers can truly learn about our iMicrodose packs and the origins of the product, as well as hope to receive important customer feedback, as we want to give all consumers a voice for important information gathering and responsible-use feedback via our planned iMIC activation.”

“Red Light Holland has definitely already taken initial steps to modernize the industry, in the Netherlands, and we are so pleased to reach an agreement to house their responsible use product in our Tiel, Location, expected in Early October, 2020,” added Dan Cohen, CEO of PharmaDrug. “Together we want to elevate the industry, educate consumers and intelligently target all Adult Demographics for potential increased sales via new customers with an informational, technological and modern approach.”

Super Smart’s Tiel location is located in Central Netherlands and is the only smart shop within a 75 kilometre radius. iMicrodose Packs powered by Red Light Holland are expected to be in Smart Shop’s Tiel store in October, 2020.

https://orders.newsfilecorp.com/files/2017/64718_a8f225a094f53bdb_001full.jpg

About Red Light Holland Corp.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland $TRIP.ca Reaches Distribution Agreement for iMicrodose Packs $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Red Light Holland’s $TRIP.ca iMicrodose Packs Are Now Available For Purchase In Stores and Online In The Netherlands Plus Launch Event and Livestream Update $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM at 10:25 AM on Friday, September 25th, 2020

Toronto, Ontario–(Newsfile Corp. – September 25, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce their iMicrodose Packs (“iMicrodose Packs“) powered by Red Light Holland are now available in stores and online for purchase in the Netherlands. Red Light Holland would also like to update the time for their launch event of iMicrodose (the “iMicrodose Launch Event“), Microdosing Packs, in the Netherlands from 5-8pm (CEST) today (Friday, September 25th, 2020) with a global livestream starting at approximately 6:30pm and ending around 7:00pm (CEST) / 12:30-1:00pm (EST). The Global Livestream will be made available at:

glsr.live/iMicrodose and/or www.RedLightTruffles.com

“We are so proud. Our small team, including our President Hans Derix, have all worked extremely hard to get us to this momentous day for the company. Seriously, this is truly a magical day. On May 28th, I went on record saying Red Light Holland would aim to have product on shelves by the end of Q3, 2020. We have delivered and achieved that goal,” said Todd Shapiro, Chief Executive Officer and Director of the Company. “Today, from 5-8pm (CEST) at our iMicrodose Launch Event we will celebrate this first big win, but we recognize it’s just an initial step in our overall business plan and ultimate growth strategy in both building a responsible use recreational brand while continuing to develop our Science and Innovation division.”

**Pictured: iMicrodose Packs powered by Red Light Holland**

Red Light Holland’s iMicrodose Packs are now available for purchase in The Netherlands (18+) at www.iMicrodose.nl and currently at the following locations: (i) two Tatanka locations (ii) the Headshop and (iii) plus Tatanka’s website at www.tatanka.nl

Update: The iMicrodose Launch Event time has been updated and will be held today Friday, September 25th, 2020, in Amsterdam at the A’DAM the Loft from 5-8 p.m (CEST) for press, artists, thought-leaders, successful entrepreneurs, local celebrities, and social media influencers. The event will feature a global live stream presentation at approximately 6:30pm (CEST) by CEO Todd Shapiro, as well as President Hans Derix and will feature local live artists and DJs including Manuel Broekman, Geza Weisz, Loes van Delft, Amanda van Effrink, aka #GLITZIEGAL and Daan Noppen.

The link to the global livestream will be available on the company’s website www.redlighttruffles.com and/or at glsr.live/iMicrodose

About Red Light Holland Corp.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland’s $TRIP.ca iMicrodose Packs Are Now Available For Purchase In Stores and Online In The Netherlands Plus Launch Event and Livestream Update $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Red Light Holland $TRIP.ca Grants Exclusive Access to a Prominent Canadian Production Company and Film Crew to Document the Company in the Netherlands $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM at 10:04 AM on Monday, September 21st, 2020

Toronto, Ontario–(Newsfile Corp. – September 21, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has granted a prominent Canadian production company and film crew exclusive access to provide video coverage of the activities of the Company and its Chief Executive Officer, Todd Shapiro, within the Netherlands, leading up to the Company’s previously announced iMicrodose product launch party (the “iMicrodose Launch Party“), scheduled on September 25, 2020, in Amsterdam, the Netherlands. Filming commenced on September 20, 2020 in Horst, the Netherlands (the location of the Company’s production and distribution facility) and will continue through to the iMicrodose Launch Party, covering, among other things, the iMicrodose brand, and the production and distribution facility.

“I’m so grateful for this production company reaching out and offering to document our journey. There’s a ton of hard work that is going on behind the scenes and if all goes according to plan – this will be another piece of earned Media, which hasn’t cost Red Light Holland a dime, to potentially highlight our Company, our tireless efforts and our iMicrodose brand to a much bigger widespread audience,” said Chief Executive Officer and Director of the Company, Todd Shapiro. “Out of respect to the production company’s intellectual property rights, which play a huge role in stimulating innovation and creativity – in this case focusing on Red Light Holland’s early magic truffles production facility, our iMicrodose product launch in the Netherlands, and our expected iMicrodose Launch Party – we’ve mutually agreed to hold off on providing more information for now. However, we look forward to sharing more details in early 2021 about this great exposure opportunity… Now let’s just hope my mug doesn’t get left on the cutting room floor!”

About Red Light Holland Corp.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks, tsx
Posted in All Recent Posts, Thoughtful Brands Inc. | Comments Off on Red Light Holland $TRIP.ca Grants Exclusive Access to a Prominent Canadian Production Company and Film Crew to Document the Company in the Netherlands $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 9:57 AM on Monday, September 21st, 2020

SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17

Raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16
The company offered 0.8 million more ADSs than anticipated
At pricing, the company raised 27% more in proceeds than expected

Contributor: Renaissance Capital

COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27% more in proceeds than expected.

COMPASS Pathways plans to list on the Nasdaq under the symbol CMPS. Cowen, Evercore ISI and Berenberg acted as lead managers on the deal.

The company is focusing on using its proprietary formulation of psilocybin, COMP360, in conjunction with psychological support as a way to help individuals who have treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD. COMPASS is currently evaluating COMP360 in conjunction with psychological support in a Phase 2b trial and plans to report data from this trial in late 2021. Classified as a Schedule I drug, psilocybin is considered a serotonergic hallucinogen and is an active ingredient in some species of mushrooms.

The article Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 originally appeared on IPO investment manager Renaissance Capital’s web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital’s research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital’s Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source: https://www.nasdaq.com/articles/can-magic-mushrooms-treat-depression-biotech-compass-pathways-prices-upsized-us-ipo-above

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks
Posted in Red Light Holland | Comments Off on Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics $SHRM.ca $RVV.ca

Posted by AGORACOM at 9:14 AM on Thursday, September 17th, 2020

Toronto, Ontario–(Newsfile Corp. – September 17, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that Red Light Holland’s Science and Innovation division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has joined the Medical Psychedelics Working Group (“MPWG“), a consortium of drug science experts, leading academics and researchers, policy specialists and industry partners. MPWG’s aim is to create a rational and enlightened approach to psychedelic research and clinical treatment. MPWG will explore innovation within the psychedelic space with a specific focus on how psychedelics can be integrated into primary and secondary healthcare. The Company believes that evidence-based science, sharing data, and strong partnerships are keys to success for the psychedelic community.

“We are elated to join the most respected experts in the industry. To be able to have open communication with leading academics like Professor David Nutt, Dr. Robin Carhart-Harris and Dr. Jo Neill is a major development for Scarlette Lillie Science and Innovation. Access is key in life and having access to the top minds in this sector is something we are all very excited about,” said Red Light Holland CEO and Director, Todd Shapiro.

“When we were approached by Red Light Holland’s Scarlette Lillie Science and Innovation, we were more than happy to include them in this very important working group. We are grateful for their support and we recognize the Company’s genuine and authentic approach to helping make positive change in this world through psilocybin research, education and information. We are thrilled to have Scarlette Lillie join our very MPWG,” stated Professor Jo Neill.

“Both Sarah Hashkes and I are pleased to be able to brainstorm and continue developing these important synergies with our peers in the field of Medical and Science Research to help elevate the Psychedelic Sector as a whole,” added Dr. Joe Geraci, Scarlette Lillie’s Scientific Advisor and CEO of Netramark.

About MPWG

MPWG is a working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes.

About Red Light Holland Corp.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks, tsx
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics $SHRM.ca $RVV.ca

Berkeley Opens Its Mind to Psychedelics with New Research Centre SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posted by AGORACOM at 9:57 AM on Wednesday, September 16th, 2020

Sponsor: Red Light Holland’s goal is to grow, distribute and market a premium brand of magic truffles to the legal, recreational market within the Netherlands, and we can’t wait to shift the existing paradigm to direct further attention to the legal and responsible use of magic truffles. Click Here For More Info

The University of California at Berkeley is getting the dirt on mushrooms.

The school announced on Monday that it will be launching the UC Berkeley Center for the Science of Psychedelics — an institute devoted to expanding and better understanding the effects hallucinogens have on the human brain, according to Marijuana Moment.

“There’s never been a better time to start a centre like this,” said neuroscientist David Presti, one of the founding members of the project. “The renewal of basic and clinical science with psychedelics has catalyzed interest among many people.”

Buoyed by an anonymous US$1.2-million donation, the centre will begin its research by looking at psilocybin — the hallucinogenic component of mushrooms that has received increased attention at other institutions recently for its ability to treat conditions previously thought untreatable.

“Some of these studies have produced striking results in cases that are otherwise resistant to more conventional medical treatment,” said Michael Silver, a neuroscientist and the director of the new centre. “This suggests that psychedelic compounds may offer new hope for people suffering from these disorders.”

Researchers are also working with the university’s graduate theological union to train students to be “facilitators” during psychedelic ceremonies with a focus on the “cultural, contemplative and spiritual care dimensions of psychedelics.”

Study at the centre will be geared toward understanding what happens in the human brain during a psychedelic experience. Researchers hope to gain insight into how visual hallucinations manifest themselves in the brain and the effect they have on a person’s identity, ability to cope with stress and even their social and political attitudes.

“Psychedelic medicines can open a doorway to seeing one’s psyche and connection with the world in new and helpful ways,” Presti said. “That’s been appreciated by shamanic traditions for thousands of years. Science is now exploring new ways to investigate this.”

Currently, psilocybin mushrooms are classified as a Schedule I drug by the FDA, the same category as heroin and cannabis. To be a Schedule I drug means the substance in question holds no medicinal value. As researchers find mushrooms have a positive effect on anxiety, treatment-resistant depression, and Seasonal Affective Disorder, that could change.

Like cannabis, psilocybin has a long track record of relative safety among recreational users, and it is not toxic. Unlike some drugs that treat anxiety and other mental conditions, psilocybin is not prone to dependence. But given its hallucinogenic effect, lawmakers may be reticent to allow distribution of the psychedelic drug without more restrictions.

SOURCE: https://theprovince.com/wellness/berkeley-opens-its-mind-to-psychedelics-with-new-research-centre/wcm/3ae4ae9e-7f88-42cf-9e17-ba77318dd03c/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, stocks, tsx, tsx-v
Posted in All Recent Posts, Red Light Holland | Comments Off on Berkeley Opens Its Mind to Psychedelics with New Research Centre SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posts Tagged ‘#Research’

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17

Categories